Molbio Diagnostics IPO Day 1 Subscription Status: Issue Booked 0.20x  so Far

Mumbai, August 10: Molbio Diagnostics IPO opened for subscription on Monday, August 10, with investors placing bids across categories in the early part of the session. By 11:54 AM, the ₹939.70 crore issue had been subscribed 0.20 times. 

Retail investors accounted for the strongest demand among the main public categories, with their portion subscribed 0.32 times. The NII category stood at 0.16 times, while the QIB portion, excluding anchor investors, had received relatively limited bids at this stage. The employee quota, however, was already subscribed 1.29 times. 

The issue will remain open until August 12, 2026. Molbio Diagnostics has set the price band at ₹768 to ₹807 per share, with investors able to bid in lots of 18 shares. 

Molbio Diagnostics IPO Day 1 Subscription Status 

The Molbio Diagnostics IPO was subscribed 0.20 times as of 11:54 AM on August 10, 2026, according to the latest subscription data.

Investors had bid for 16,04,628 shares against 81,58,529 shares offered across the public and employee categories. The employee portion had already crossed the full-subscription mark, while the QIB, NII and retail portions were yet to reach 1x. 

The overall subscription calculation excludes the shares allotted to anchor investors. 

Category-wise Molbio Diagnostics IPO Subscription Status 

Retail investors had bid for 12,96,792 shares against 40,69,004 shares reserved for the category. This translated into a subscription of 0.32 times. 

The NII category received bids for 2,79,918 shares against 17,43,859 shares on offer. Within the segment, the sNII portion had attracted more bids than the bNII portion so far. 

The QIB category, after excluding the anchor allocation, had received bids for 1,494 shares against 23,25,146 shares available to the category. 

Within the NII category, the bNII segment, covering applications above ₹10 lakh, was subscribed 0.11 times. The sNII segment, covering applications below ₹10 lakh, was subscribed 0.27 times. 

Molbio Diagnostics IPO Day-Wise Subscription Summary 

August 10 marks the first day of bidding for the issue. By 11:54 AM, the overall subscription had reached 0.20 times. 

The employee portion was the first category to move beyond full subscription. Among the main investor groups, retail investors had recorded the highest subscription at 0.32 times, followed by NII at 0.16 times. 

Molbio Diagnostics IPO Timeline 

Brief Overview Of The IPO 

Molbio Diagnostics IPO is a ₹939.70 crore bookbuilding issue with a price band of ₹768 to ₹807 per share. The issue opened on August 10 and will close on August 12, 2026. 

The IPO comprises a fresh issue of 24,80,246 shares aggregating up to ₹200 crore and an offer for sale of 91,66,000 shares aggregating up to ₹740 crore. 

The lot size is 18 shares. At the upper end of the price band, one retail lot requires an investment of ₹14,526. 

Of the net offer, 58,12,863 shares, or 50%, are reserved for QIBs, 17,43,859 shares, or 15%, for NIIs and 40,69,004 shares, or 35%, for retail investors. The QIB allocation includes 34,87,717 shares reserved for anchor investors. 

A separate reservation of 20,520 shares has been made for employees, who are eligible for a ₹76 discount to the issue price. 

Kotak Mahindra Capital Co. Ltd. is the book running lead manager, while Kfin Technologies Ltd. is the registrar to the issue. The shares are scheduled to list on the NSE on August 17, 2026.  

Source: 

• https://www.chittorgarh.net/reports/anchor-investor/molbio-ipo-anchor.pdf